Glancy prongay & murray llp, a leading securities fraud law firm encourages revance therapeutics, inc. (rvnc) investors to inquire about securities fraud class action

Los angeles--(business wire)--glancy prongay & murray llp, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired revance therapeutics, inc. (“revance” or the “company”) (nasdaq: rvnc) securities between february 29, 2024 and december 6, 2024, inclusive (the “class period”). revance investors have until march 4, 2025 to file a lead plaintiff motion. if you suffered a los.
RVNC Ratings Summary
RVNC Quant Ranking